how to integrate perioperative immunotherapy into multimodal treatment plans in resectable nsclc
Published 2 years ago • 713 plays • Length 49:11Download video MP4
Download video MP3
Similar videos
-
43:46
realizing the promise of perioperative immunotherapy in resectable nsclc
-
48:44
neoadjuvant, adjuvant, or both: individualized perioperative immunotherapy in resectable nsclc
-
53:19
improving survival and cure rates in resectable nsclc with perioperative immunotherapy
-
1:05:29
can the addition of immunotherapy to multimodal management of stage i-iii nsclc improve outcomes?
-
41:23
multimodal management of early-stage nsclc: egfr-targeted therapy in perioperative settings
-
39:06
unleashing the potential of perioperative immunotherapy in resectable nsclc
-
59:37
marking new milestones with immunotherapy in locally advanced and early lung cancer
-
59:24
marking new milestones with immunotherapy in locally advanced and early lung cancer
-
1:01:06
iaslc webinar: perioperative treatment w/immune checkpoint inhibitors in patients w/resectable nsclc
-
1:44:45
gaining an advantage over nsclc: how to achieve the greatest benefit with immunotherapy
-
1:11:16
immunotherapy as a game-changer in multimodal management of lung cancer
-
1:08:00
has immunotherapy brought us to an inflection point in the management of stage i-iii nsclc?
-
1:06:23
immunotherapy in lung cancer: rationale, evidence, and implications for the multidisciplinary team
-
7:00
expert report on neoadjuvant immune checkpoint inhibitors for nsclc
-
1:10:20
watch drs broderick & wakelee discuss the latest in nsclc: https://bit.ly/2021-nsclc
-
1:04:49
navigating multidisciplinary care with immunotherapy in esophageal/gej cancer
-
43:35
maximizing the impact of egfr-targeted therapy in resectable nsclc
-
38:09
understanding and working with new immunotherapeutic and targeted management models in advanced rcc
-
26:32
standard and alternative dosing regimens of immunotherapies and combinations in modern oncology